BJ
ENZN

BlackRock Japan’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

BlackRock Japan’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-9,274
Closed -$4K – 1565
2016
Q1 		$4K Sell
9,274
-334
-3% -$163 ﹤0.01% 1389
2015
Q4 		$7K Sell
9,608
-584
-6% -$463 ﹤0.01% 1312
2015
Q3 		$10K Sell
10,192
-1,010
-9% -$1.24K ﹤0.01% 1177
2015
Q2 		$13K Sell
11,202
-24,029
-68% -$30.6K ﹤0.01% 1252
2015
Q1 		$37K Hold
35,231
– – ﹤0.01% 1117
2014
Q4 		$38K Sell
35,231
-3,036
-8% -$3.19K ﹤0.01% 1140
2014
Q3 		$41K Sell
38,267
-24,914
-39% -$30.8K ﹤0.01% 1081
2014
Q2 		$66K Sell
63,181
-10,256
-14% -$9.77K ﹤0.01% 1000
2014
Q1 		$76K Hold
73,437
– – ﹤0.01% 1105
2013
Q4 		$85K Buy
73,437
+1,884
+3% +$2.9K ﹤0.01% 1059
2013
Q3 		$120K Hold
71,553
– – ﹤0.01% 982
2013
Q2 		$143K Buy
+71,553
New +$209K ﹤0.01% 926

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

BlackRock Japan's ENZN Position: Q2 2016 in Review

BlackRock Japan sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 9,274 shares — an estimated $4K sold.

BlackRock Japan first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $143K in Q2 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • BlackRock Japan reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • BlackRock Japan sold 9,274 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $4K.
  • BlackRock Japan first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
  • BlackRock Japan's ENZON PHARMACEUTICALS INC position peaked at $143K in Q2 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on BlackRock Japan's 13F filing for Q2 2016, filed 10 Aug 2016.